AR019327A1 - Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana - Google Patents

Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana

Info

Publication number
AR019327A1
AR019327A1 ARP990102919A ARP990102919A AR019327A1 AR 019327 A1 AR019327 A1 AR 019327A1 AR P990102919 A ARP990102919 A AR P990102919A AR P990102919 A ARP990102919 A AR P990102919A AR 019327 A1 AR019327 A1 AR 019327A1
Authority
AR
Argentina
Prior art keywords
apomorphine
treatment
combination
dysfunction
fentolamine
Prior art date
Application number
ARP990102919A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR019327A1 publication Critical patent/AR019327A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe un método para el tratamiento de la disfuncion sexual que comprende administrar una cantidad terapéuticamente efectiva de una combinacion defentolamina y apomorfina, como así también composiciones farmacéuticas y equipos utiles en aquellos métodos.
ARP990102919A 1998-06-19 1999-06-17 Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana AR019327A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/100,562 US6011043A (en) 1998-06-19 1998-06-19 Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction

Publications (1)

Publication Number Publication Date
AR019327A1 true AR019327A1 (es) 2002-02-13

Family

ID=22280390

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102919A AR019327A1 (es) 1998-06-19 1999-06-17 Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana

Country Status (8)

Country Link
US (2) US6011043A (es)
EP (1) EP1087767A2 (es)
AR (1) AR019327A1 (es)
AU (1) AU4676099A (es)
CA (1) CA2334924A1 (es)
CO (1) CO5050343A1 (es)
PE (1) PE20000701A1 (es)
WO (1) WO1999065475A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030004170A1 (en) * 1997-05-19 2003-01-02 Zonagen, Inc. Combination therapy for modulating the human sexual response
AU4203600A (en) * 1999-04-06 2000-10-23 Zonagen, Inc. Methods for modulating the human sexual response
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
CA2479372A1 (en) * 2002-03-19 2003-10-02 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
GB0221711D0 (en) * 2002-09-19 2002-10-30 Ardana Bioscience Ltd Methods
ES2359977T3 (es) 2003-03-31 2011-05-30 Titan Pharmaceuticals, Inc. Dispositivo polimérico implantable para liberación sostenida de agonista de dopamina.
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
EP2545905A1 (en) 2011-07-11 2013-01-16 Britannia Pharmaceuticals Limited A new therapeutical composition containing apomorphine as active ingredient
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
DK0996447T3 (da) * 1997-05-19 2006-11-13 Zonagen Inc Kombinationsbehandling til modulation af det humane seksuelle respons

Also Published As

Publication number Publication date
CA2334924A1 (en) 1999-12-23
WO1999065475A3 (en) 2000-04-06
WO1999065475A2 (en) 1999-12-23
US6136818A (en) 2000-10-24
US6011043A (en) 2000-01-04
EP1087767A2 (en) 2001-04-04
PE20000701A1 (es) 2000-08-16
AU4676099A (en) 2000-01-05
CO5050343A1 (es) 2001-06-27

Similar Documents

Publication Publication Date Title
NO2012015I2 (no) Dapoxetine
AR012304A1 (es) Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos.
ECSP056159A (es) Composición de fármaco conjugado
DE60115842D1 (de) Ventilanordnung
HN1999000080A (es) Derivados de isotiazol utiles como agentes anticancerosos.
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
ECSP045429A (es) Combinacion de compuestos organicos
UY28860A1 (es) Procedimiento para el tratamiento de trastornos premenstruales y otros trastornos sexuales femeninos
GT199700009AA (es) Terapia combinada para la osteoporosis
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
ECSP045153A (es) Metodo y composición para aumentar la potencia de un analgésico de narcotico.
PE20020909A1 (es) Una combinacion que comprende combretastatina y agentes anticancerigenos
AR019327A1 (es) Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana
AR021912A1 (es) Uso de apomorfina para el tratamiento de la disfuncion erectil organica en varones
MXPA02009904A (es) Derivados de apomorfina y metodos para su uso.
BR9707247A (pt) Diidrobenzofurano e compostos relacionados úteis como agentes antiinflamatórios
AR022017A1 (es) Un agente para tratar el trastorno de la funcion de las celulas visuales. el metodo de tratamiento y el uso de dicho agente para la produccion de unacomposicion farmaceutica
ECSP993026A (es) Combinacion de fentolamina y apomorfina para el tratamiento de la funcion y disfuncion sexual humana
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
AR027037A1 (es) Compusto y metodo para el tratamiento del dolor
AR026756A1 (es) Nuevas combinaciones terapeuticas (s)-2-bencilamino-metil)-2,3,8,9-tetrahidro-7h-1,4-dioxino[2,3-e]indol-8-ona y neuroleticos para el tratamiento oprevencion de desordenes psicoticos
AR020741A1 (es) Composicion y metodo para tratar enfermedades alergicas
ECSP972190A (es) Piridinas sustituidas como inhibidores selectivos de ciclooxigenasa 2
AR048128A1 (es) Un tratamiento de la difuncion sexual

Legal Events

Date Code Title Description
FB Suspension of granting procedure